These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25389329)

  • 1. p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement.
    Reuschenbach M; Wentzensen N; Dijkstra MG; von Knebel Doeberitz M; Arbyn M
    Am J Clin Pathol; 2014 Dec; 142(6):767-72. PubMed ID: 25389329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
    Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
    J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.
    Tao AS; Zuna R; Darragh TM; Grabe N; Lahrmann B; Clarke MA; Wentzensen N
    Am J Clin Pathol; 2024 Aug; 162(2):202-209. PubMed ID: 38527169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of p16(INK4a) immunohistochemistry staining on interobserver agreement on the diagnosis of cervical intraepithelial neoplasia.
    Pacchiarotti A; Galeotti S; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
    Am J Clin Pathol; 2014 Mar; 141(3):367-73. PubMed ID: 24515764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies.
    Gurrola-Díaz CM; Suárez-Rincón AE; Vázquez-Camacho G; Buonocunto-Vázquez G; Rosales-Quintana S; Wentzensen N; von Knebel Doeberitz M
    Gynecol Oncol; 2008 Oct; 111(1):120-4. PubMed ID: 18692882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia.
    Horn LC; Reichert A; Oster A; Arndal SF; Trunk MJ; Ridder R; Rassmussen OF; Bjelkenkrantz K; Christiansen P; Eck M; Lorey T; Skovlund VR; Ruediger T; Schneider V; Schmidt D
    Am J Surg Pathol; 2008 Apr; 32(4):502-12. PubMed ID: 18223479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia.
    Klaes R; Benner A; Friedrich T; Ridder R; Herrington S; Jenkins D; Kurman RJ; Schmidt D; Stoler M; von Knebel Doeberitz M
    Am J Surg Pathol; 2002 Nov; 26(11):1389-99. PubMed ID: 12409715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia.
    Bergeron C; Ordi J; Schmidt D; Trunk MJ; Keller T; Ridder R;
    Am J Clin Pathol; 2010 Mar; 133(3):395-406. PubMed ID: 20154278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining.
    Negri G; Moretto G; Menia E; Vittadello F; Kasal A; Mian C; Egarter-Vigl E
    J Clin Pathol; 2006 Aug; 59(8):827-30. PubMed ID: 16467166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of immunohistochemical overexpression of p16 in the histologic diagnosis of cervical intraepithelial neoplasia grade 2.
    Forteza A; Vanrell C; Matheu G; Cortés J
    Rev Esp Patol; 2024; 57(3):169-175. PubMed ID: 38971616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
    Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
    Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis.
    Roelens J; Reuschenbach M; von Knebel Doeberitz M; Wentzensen N; Bergeron C; Arbyn M
    Cancer Cytopathol; 2012 Oct; 120(5):294-307. PubMed ID: 22700382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results.
    Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K
    Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
    Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
    BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN Study.
    Stoler MH; Wright TC; Ferenczy A; Ranger-Moore J; Fang Q; Kapadia M; Ridder R
    Am J Surg Pathol; 2018 Aug; 42(8):1001-1009. PubMed ID: 29697437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.